NSC21171
dc.creator | US National Cancer Institute | en_GB |
dc.date.accessioned | 2005-01-25T10:09:21Z | |
dc.date.available | 2005-01-25T10:09:21Z | |
dc.date.created | 2003-02-01 | en_GB |
dc.date.issued | 2005-01-25T10:09:21Z | |
dc.identifier | NSC21171 | en_GB |
dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/24050 | |
dc.format.extent | 11096 bytes | |
dc.format.extent | 9786 bytes | |
dc.format.mimetype | chemical/x-cml | |
dc.format.mimetype | chemical/x-cml | |
dc.language.iso | en_GB | |
dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
dc.title | NSC21171 | en_GB |
dc.title.alternative | (6.alpha.-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl- | en_GB |
dc.title.alternative | Depcorlutin | en_GB |
dc.title.alternative | Depo-provera | en_GB |
dc.title.alternative | Depo-Promone | en_GB |
dc.title.alternative | Depo-Provera | en_GB |
dc.title.alternative | Depomedroxyprogesterone acetate | en_GB |
dc.title.alternative | Deporone | en_GB |
dc.title.alternative | Depot-medroxyprogesterone acetate | en_GB |
dc.title.alternative | DMPA | en_GB |
dc.title.alternative | DP150 | en_GB |
dc.title.alternative | Farlutin | en_GB |
dc.title.alternative | Gestapuran | en_GB |
dc.title.alternative | Lutopolar | en_GB |
dc.title.alternative | Lutoral | en_GB |
dc.title.alternative | Medroxyprogesterone acetate | en_GB |
dc.title.alternative | Metigestrona | en_GB |
dc.title.alternative | MAP | en_GB |
dc.title.alternative | MPA (VAN) | en_GB |
dc.title.alternative | Nadigest | en_GB |
dc.title.alternative | Nidaxin | en_GB |
dc.title.alternative | Nogest | en_GB |
dc.title.alternative | Oragest | en_GB |
dc.title.alternative | ONCO-Provera | en_GB |
dc.title.alternative | Perlutex | en_GB |
dc.title.alternative | Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6.alpha.)- (9CI) | en_GB |
dc.title.alternative | Pregn-4-ene-3, 20-dione, 17-hydroxy-6.alpha.-methyl-, acetate (8CI) | en_GB |
dc.title.alternative | Prodasone | en_GB |
dc.title.alternative | Progestalfa | en_GB |
dc.title.alternative | Progesterone, 17-hydroxy-6.alpha.-methyl-, acetate | en_GB |
dc.title.alternative | Progevera | en_GB |
dc.title.alternative | Promone-E | en_GB |
dc.title.alternative | Provera | en_GB |
dc.title.alternative | Proverone | en_GB |
dc.title.alternative | Repromix | en_GB |
dc.title.alternative | Sirprogen | en_GB |
dc.title.alternative | Supprestral | en_GB |
dc.title.alternative | U 8839 | en_GB |
dc.title.alternative | Veramix | en_GB |
dc.title.alternative | 17.alpha.-Acetoxy-6.alpha.-methylprogesterone | en_GB |
dc.title.alternative | 17.alpha.-Acetoxy-6-.alpha.-methylpregn-4-ene-3,20-dione | en_GB |
dc.title.alternative | 17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione acetate | en_GB |
dc.title.alternative | 17.alpha.-Hydroxy-6.alpha.-methylprogesterone acetate | en_GB |
dc.title.alternative | 17.alpha.-Hydroxy-6-.alpha.-methylprogesterone acetate | en_GB |
dc.title.alternative | 17-Acetoxy-6.alpha.-methylprogesterone | en_GB |
dc.title.alternative | 6.alpha.-Methyl-17.alpha.-acetoxypregn-4-ene-3,20-dione | en_GB |
dc.title.alternative | 6.alpha.-Methyl-17.alpha.-acetoxyprogesterone | en_GB |
dc.title.alternative | 6.alpha.-Methyl-17.alpha.-hydroxyprogesterone acetate | en_GB |
dc.title.alternative | 6.alpha.-Methyl-17-acetoxyprogesterone | en_GB |
dc.title.alternative | 6.alpha.-Methyl-4-pregnene-3,20-dion-17.alpha.-ol acetate | en_GB |
dc.type | Chemical Structures | en_GB |
dc.identifier.inchikey | PSGAAPLEWMOORI-PEINSRQWSA-N | |
dc.identifier.inchi | InChI=1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1 | |
dc.identifier.ichi | C24H34O4,1H3-14(25)24(28-15(2H3)26)12H2-9H2-21H-19H-13H2-18H(3H3)17-6H-16(27)7H2-10H2-22(17,4H3)20H(19)8H2-11H2-23(21,24)5H3 | en_GB |
Files in this item
This item appears in the following Collection(s)
-
WWMM
The WorldWideMolecularMatrix, an Open collection of information on small molecules